This book unpacks the organized sets of practices that govern contemporary Asian medicine, from production of medications in the lab to their circulation within circuits and networks of all kinds, and examines the plurality of actors involved in such governance.
Chapters analyze the process of industrialization and commercialization of Asian medicine and the ways in which the expansion of the market in Asian medicines has contributed to the inscription of products within a large system of governance, greatly dominated by global actors and the biomedical hegemony. At the same time, the contributors argue that local actors continue to play a major role in reshaping the regulations and their implementation, thus complexifying the trajectory of the remedies and their natures. Examining in particular the plurality of actors involved in governance and circulation, and the converging or conflicting logics actors follow in regard to negotiations and tensions that arise, the book brings a unique multi-layered contribution to the study of governance and circulation of Asian medicines, offering further proof of their fluidity and resilience.
Filling a significant gap in the market by addressing circulation and governance of Asian medicines in Asian countries, including Bangladesh, Myanmar, and Singapore, this book will be of interest to students and scholars in the field of Asian studies, Asian culture and society, global health, Asian medicine, and medical anthropology.
Introduction: Governance and Circulation of Asian Medicines, Céline Coderey; 1 WHOse Guidelines Matter? The Politics of Regulating Traditional Medicine in Bangladesh, Karen M. McNamara; 2 Science as Global Governance and Circulation tool? The Baekshuoh Disaster in South Korea, Eunjeong Ma; 3 Governing Medical Traditions in Myanmar, Céline Coderey; 4 Negotiating Chinese Medical Value and Authority in the (Bio)polis, Arielle A. Smith; 5 "Health Products" at the Boundary between Food and Pharmaceuticals: The Case of Fish Liver Oil, Liz P.Y. Chee; 6 Globalized Planta Medica and Processes of Drug Validation: The Artemisinin Enterprise, Caroline Meier zu Biesen; 7 Circumventing Regulation and Professional Legitimization. The Circulation of Chinese Medicine between China and France, Simeng Wang; Afterword: Governance, Circulation, and Pharmaceutical Objects, Laurent Pordié